AU6349599A - Use of xanthan gums for preparing pharmaceutical compositions - Google Patents

Use of xanthan gums for preparing pharmaceutical compositions

Info

Publication number
AU6349599A
AU6349599A AU63495/99A AU6349599A AU6349599A AU 6349599 A AU6349599 A AU 6349599A AU 63495/99 A AU63495/99 A AU 63495/99A AU 6349599 A AU6349599 A AU 6349599A AU 6349599 A AU6349599 A AU 6349599A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
preparing pharmaceutical
xanthan gums
xanthan
gums
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63495/99A
Other languages
English (en)
Inventor
Guy Couarraze
Claire Le Martret
Didier Tanguy
Pierre Tchoreloff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhodia Chimie SAS
Original Assignee
Rhodia Chimie SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhodia Chimie SAS filed Critical Rhodia Chimie SAS
Publication of AU6349599A publication Critical patent/AU6349599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
AU63495/99A 1998-11-02 1999-11-02 Use of xanthan gums for preparing pharmaceutical compositions Abandoned AU6349599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9813743A FR2785191B1 (fr) 1998-11-02 1998-11-02 Utilisation de gommes xanthanes pour la preparation de compositions pharmaceutiques
FR9813743 1998-11-02
PCT/FR1999/002672 WO2000025749A1 (fr) 1998-11-02 1999-11-02 Utilisation de gommes xanthanes pour la preparation de compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
AU6349599A true AU6349599A (en) 2000-05-22

Family

ID=9532264

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63495/99A Abandoned AU6349599A (en) 1998-11-02 1999-11-02 Use of xanthan gums for preparing pharmaceutical compositions

Country Status (4)

Country Link
EP (1) EP1126825A1 (fr)
AU (1) AU6349599A (fr)
FR (1) FR2785191B1 (fr)
WO (1) WO2000025749A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015284078B2 (en) 2014-07-03 2020-01-30 SpecGx LLC Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292534A (en) * 1992-03-25 1994-03-08 Valentine Enterprises, Inc. Sustained release composition and method utilizing xanthan gum and an active ingredient
FR2729857B1 (fr) * 1995-01-27 1997-04-04 Rhone Poulenc Chimie Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire

Also Published As

Publication number Publication date
EP1126825A1 (fr) 2001-08-29
WO2000025749A9 (fr) 2002-08-22
WO2000025749A1 (fr) 2000-05-11
FR2785191A1 (fr) 2000-05-05
FR2785191B1 (fr) 2002-05-31

Similar Documents

Publication Publication Date Title
AU762322C (en) Novel galenic formulations of meloxicam for oral administration
AU7389300A (en) Methods of administration of glycopyrrolate compositions
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU4949800A (en) 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
AU3192700A (en) Medicinal compositions
AU4413299A (en) Stabilized pharmaceutical compositions
AU5326100A (en) Pharmaceutical compositions and methods for use
AU3556400A (en) Pharmaceutical compositions
AU2001269198A1 (en) Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
AU2005300A (en) Medicinal compositions
AU1574900A (en) Pharmaceutical compositions containing insulin
AU4428000A (en) Pulse-delivery oral compositions
AU4304400A (en) Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
AU2564399A (en) Isoflavanoid formulations for oral administration
AU2001292331A2 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001292331A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU6460400A (en) Pharmaceutical compositions
AU1732401A (en) Medicinal compositions for oral use
AU5326298A (en) Pharmaceutical compositions containing N-sulphonylindoline derivatives
AU4913399A (en) Thioazepinone derivatives, preparation method and intermediates therefor, use asmedicines and pharmaceutical compositions containing same
AU6460200A (en) Pharmaceutical compositions
HUP0200993A3 (en) Thio-oxindole derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
AU6460100A (en) Pharmaceutical compositions
AU6460300A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase